金石亚药：10月22日召开董事会会议

Group 1 - The core point of the article is that Jinshi Yiyao (SZ 300434) announced its third-quarter report for 2025 during a board meeting held on October 22, 2025, in Hangzhou, Zhejiang [1] - For the first half of 2025, the revenue composition of Jinshi Yiyao is as follows: 82.76% from the pharmaceutical manufacturing industry, 14.09% from the machinery manufacturing industry, and 3.16% from real estate leasing and management [1] - As of the report, Jinshi Yiyao has a market capitalization of 4.6 billion yuan [1]